Since the relationship between levels of amplification and overexpression is currently unclear, from a clinical perspective, it will be of interest to determine the prognostic significance of AXL amplification-dependent overexpression in sarcoma tumors in the future. The gene discussed is AXL; the disease is sarcoma.